US Bancorp’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$245K Sell
18,011
-6,000
-25% -$89.9K ﹤0.01% 1905
2025
Q4
$369K Sell
24,011
-1,480
-6% -$23.7K ﹤0.01% 1702
2025
Q3
$418K Buy
25,491
+1,480
+6% +$24.3K ﹤0.01% 1615
2025
Q2
$386K Hold
24,011
﹤0.01% 1635
2025
Q1
$379K Hold
24,011
﹤0.01% 1647
2024
Q4
$394K Hold
24,011
﹤0.01% 1630
2024
Q3
$426K Buy
+24,011
New +$417K ﹤0.01% 1602

Other funds holding ECAT

US Bancorp's ECAT Position: Q1 2026 in Review

US Bancorp reduced its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 25% in Q1 2026, selling an estimated $89.9K and leaving 18,011 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

US Bancorp first reported a position in ECAT in Q3 2024 and has held it in 7 quarters since. The position peaked at $426K in Q3 2024. 84 funds tracked by Wall St. Rank hold ECAT as of Q1 2026.

  • US Bancorp held 18,011 shares of BlackRock ESG Capital Allocation Term Trust worth $245K as of Q1 2026.
  • US Bancorp sold 6,000 BlackRock ESG Capital Allocation Term Trust shares in Q1 2026, an estimated $89.9K.
  • BlackRock ESG Capital Allocation Term Trust made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #1905 holding.
  • US Bancorp first reported a position in BlackRock ESG Capital Allocation Term Trust in Q3 2024 and has held it in 7 quarters since.
  • US Bancorp's BlackRock ESG Capital Allocation Term Trust position peaked at $426K in Q3 2024.
  • 84 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.